Revvity
Company Snapshot
Founded: 1937
Entity Type: Public
Employees: 11,000
Region: U.S.
Revenue: $2,856.1 Millions
Revenue Year: 2025
Headquarter: Waltham, Massachusetts, U.S.
Key Geographics: U.K., U.S., China, Rest of the World
Corporate Address: 77, 4th Avenue Waltham, Massachusetts 02451, U.S. Tel. +1-781-663-6900 www.revvity.com
Company Overview
Revvity supplies products and services for life sciences and diagnostic applications. In April 2023, it renamed itself Revvity Inc. from PerkinElmer Inc., and changed the ticker symbol for its common stock to "RVTY" on May 16, 2023. Its two reportable segments are life sciences and diagnostics. Its products, such as DNA and protein microarrays and LabChip systems, are utilized in clinical diagnostics, drug discovery, genomics, and proteomics. It has a global presence spanning 160 countries.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Life Sciences : Sales of instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services
- Diagnostics : Sales of instruments, solutions, consumables, reagents, and services
Applications/End User Industries
- Hospitals
- Medical Labs
- Clinicians
- Medical Research Professionals
- Research Institutions
- Pharmaceutical Companies